Menu
Back to Journals » OncoTargets and Therapy » Volume 15
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6312)
- Volume 16, 2023 (21)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 15, 2022
Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival
Cerón R, Martínez A, Ramos C, De la Cruz A, García A, Mendoza I, Palmeros G, Montaño Figueroa EH, Navarrete J, Jiménez-Morales S, Martinez-Murillo C, Olarte I
OncoTargets and Therapy 2022, 15:1583-1595
Published Date: 30 December 2022
Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer
Ho MC, Chung YS, Lin YC, Hung MS, Fang YH
OncoTargets and Therapy 2022, 15:1573-1582
Published Date: 28 December 2022
Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Clostridioides difficile Infection Among Patients with Lung Cancer
Chung YS, Lin YC, Hung MS, Ho MC, Fang YH
OncoTargets and Therapy 2022, 15:1563-1571
Published Date: 28 December 2022
Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes
Naseripour M, Mirshahi R, Kasraei H, Sedaghat A, Azimi F
OncoTargets and Therapy 2022, 15:1545-1561
Published Date: 22 December 2022
Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Response to Letter]
Reyes-Vallejo T, Conde-Rodríguez I, Serna-Villalobos J, Ramírez-Díaz I, Pérez-Villalobos G, Delgado-López G, Vázquez-Zamora VJ, Gutierrez-Quiroz CT, Ávila-Jiménez L, García-Carrancá A, Martínez-Acosta L, Santos-López G, Reyes-Leyva J, Vallejo-Ruiz V
OncoTargets and Therapy 2022, 15:1543-1544
Published Date: 22 December 2022
Targeted Therapy for Locally Advanced or Metastatic Urothelial Cancer (mUC): Therapeutic Potential of Sacituzumab Govitecan
Fontes MS, Vargas Pivato de Almeida D, Cavalin C, Tagawa ST
OncoTargets and Therapy 2022, 15:1531-1542
Published Date: 21 December 2022
Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context
Hoffman-Censits J, Maldonado L
OncoTargets and Therapy 2022, 15:1519-1529
Published Date: 15 December 2022
Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead
Tsang ES, Munster PN
OncoTargets and Therapy 2022, 15:1509-1518
Published Date: 13 December 2022
Silencing of Long Non-Coding RNA Colon Cancer-Associated Transcript 2 Inhibits the Growth and Metastasis of Gastric Cancer Through Blocking mTOR Signaling [Retraction]
Lin S, Wang H, Yang W, Wang A, Geng C
OncoTargets and Therapy 2022, 15:1507-1508
Published Date: 9 December 2022
Circular RNA PVT1 Promotes the Invasion and Epithelial–Mesenchymal Transition of Breast Cancer Cells through Serving as a Competing Endogenous RNA for miR-204-5p [Retraction]
Bian Q
OncoTargets and Therapy 2022, 15:1505-1506
Published Date: 6 December 2022
Chemotherapy Induces Ovarian Cancer Cell Repopulation Through the Caspase 3-Mediated Arachidonic Acid Metabolic Pathway [Corrigendum]
Cui LZ, Zhao YW, Pan Y, Zheng X, Shao D, Jia Y, He K, Li K, Chen L
OncoTargets and Therapy 2022, 15:1503-1504
Published Date: 5 December 2022
Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options
Vodicka P, Klener P, Trneny M
OncoTargets and Therapy 2022, 15:1481-1501
Published Date: 6 December 2022
Curcumin Potentiates the Potent Antitumor Activity of ACNU Against Glioblastoma by Suppressing the PI3K/AKT and NF-κB/COX-2 Signaling Pathways [Retraction]
Zhao J, Zhu J, Lv X, Xing J, Liu S, Chen C, Xu Y
OncoTargets and Therapy 2022, 15:1479-1480
Published Date: 2 December 2022
Therapeutic Targeting of FLT3 in Acute Myeloid Leukemia: Current Status and Novel Approaches
Tecik M, Adan A
OncoTargets and Therapy 2022, 15:1449-1478
Published Date: 30 November 2022
Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects
Tuli HS, Garg VK, Mehta JK, Kaur G, Mohapatra RK, Dhama K, Sak K, Kumar A, Varol M, Aggarwal D, Anand U, Kaur J, Gillan R, Sethi G, Bishayee A
OncoTargets and Therapy 2022, 15:1419-1448
Published Date: 30 November 2022
Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter]
Panjaitan NSD, Lienggonegoro LA, Nikmah UA
OncoTargets and Therapy 2022, 15:1417-1418
Published Date: 25 November 2022
Successful Targeting of CTLA-4 in a Melanoma Clinical Case: A Long-Term “One Stop Therapeutic Shop”
Colucci M, D'Alonzo V, Santangelo F, Miracco C, Valente M, Maio M, Di Giacomo AM
OncoTargets and Therapy 2022, 15:1409-1415
Published Date: 25 November 2022
miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1 [Retraction]
Luo X, He X, Liu X, Zhong L, Hu W
OncoTargets and Therapy 2022, 15:1407-1408
Published Date: 22 November 2022
A Response to Article Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year after Standard Treatment [Letter]
Panjaitan NSD
OncoTargets and Therapy 2022, 15:1405-1406
Published Date: 22 November 2022
HIF1 α/PD-L1 Axis Mediates Hypoxia-Induced Cell Apoptosis and Tumor Progression in Follicular Thyroid Carcinoma [Retraction]
Zhou L, Cha G, Chen L, Yang C, Xu D, Ge M
OncoTargets and Therapy 2022, 15:1403-1404
Published Date: 21 November 2022
CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current Insights
Christian SL
OncoTargets and Therapy 2022, 15:1391-1402
Published Date: 18 November 2022
Circular RNA ZNF609 Promoted Hepatocellular Carcinoma Progression by Upregulating PAP2C Expression via Sponging miR-342-3p [Retraction]
Liao X, Zhan W, Tian B, Luo Y, Gu F, Li R
OncoTargets and Therapy 2022, 15:1389-1390
Published Date: 17 November 2022
MicroRNA-211 Promotes Non-Small-Cell Lung Cancer Proliferation and Invasion by Targeting MxA [Retraction]
Kang M, Shi J, Peng N, He S
OncoTargets and Therapy 2022, 15:1387-1388
Published Date: 16 November 2022
Hsa_circ_RNA_0011780 Represses the Proliferation and Metastasis of Non-Small Cell Lung Cancer by Decreasing FBXW7 via Targeting miR-544a [Retraction]
Liu Y, Yang C, Cao C, Li Q, Jin X, Shi H
OncoTargets and Therapy 2022, 15:1385-1386
Published Date: 16 November 2022
7β-22 Dihydroxyhopane, Isolated from the Sub-Antarctic Lichen, Inhibits the Viability and Stemness in Glioma Stem Like Cells
Kim HJ, Suh SS, Park J, Shin MJ, Koo MH, Lee SJ, Jeon YJ, Lee S, Youn UJ, Kim SH
OncoTargets and Therapy 2022, 15:1375-1383
Published Date: 15 November 2022
Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation
Yagami Y, Nakahara Y, Manabe H, Yamamoto H, Otani S, Sato T, Igawa S, Kubota M, Sasaki J, Naoki K
OncoTargets and Therapy 2022, 15:1369-1374
Published Date: 11 November 2022
Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect
Yan X, Liu SM, Liu C
OncoTargets and Therapy 2022, 15:1355-1368
Published Date: 10 November 2022
A Durable Response of Primary Advanced Colonic Plasmacytoma Using a Combination of Surgical Resection and Adjuvant Bortezomib: A Case Report and Literature Review
Alfar R, Kamal N, Abdel Razeq R, Omari Z, Bater R, Sharaf B
OncoTargets and Therapy 2022, 15:1347-1354
Published Date: 7 November 2022
Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma
Colic E, Patel PU, Kent OA
OncoTargets and Therapy 2022, 15:1331-1346
Published Date: 5 November 2022
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status
Furubayashi N, Minato A, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Harada M, Tamura S, Kobayashi H, Wada Y, Kuroiwa K, Seki N, Fujimoto N, Nakamura M
OncoTargets and Therapy 2022, 15:1321-1330
Published Date: 5 November 2022
Hopea odorata Extract Inhibits Hepatocellular Carcinoma via Induction of Caspase-Dependent Apoptosis [Erratum]
Nguyen ST, Huynh KL, Nguyen HL, Nguyen Thi Thanh M, Nguyen Trung N, Nguyen Xuan H, Ngoc KP, Truong Dinh K, Pham PV
OncoTargets and Therapy 2022, 15:1319-1320
Published Date: 1 November 2022
Targeting of GIT1 by miR-149* in Breast Cancer Suppresses Cell Proliferation and Metastasis in vitro and Tumor Growth in vivo [Retraction]
Dong Y, Chang C, Liu J, Qiang J
OncoTargets and Therapy 2022, 15:1317-1318
Published Date: 31 October 2022
Ketoacidosis in a Patient with Type 2 Diabetes Requiring Alpelisib: Learnings and Observations Regarding Alpelisib Initiation and Rechallenge
Leung M, Rodrigues P, Roitman D
OncoTargets and Therapy 2022, 15:1309-1315
Published Date: 28 October 2022
In vitro Characterization of Enhanced Human Immune Responses by GM-CSF Encoding HSV-1-Induced Melanoma Cells
Delic M, Boeswald V, Goepfert K, Pabst P, Moehler M
OncoTargets and Therapy 2022, 15:1291-1307
Published Date: 27 October 2022
Snake Venom Causes Apoptosis by Increasing the Reactive Oxygen Species in Colorectal and Breast Cancer Cell Lines [Corrigendum]
Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M
OncoTargets and Therapy 2022, 15:1289-1290
Published Date: 26 October 2022
A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review
Fuji T, Arai J, Otoyama Y, Nio Y, Sugiura I, Nakajima Y, Kajiwara A, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Nozawa H, Momo K, Sasaki T, Yoshida H
OncoTargets and Therapy 2022, 15:1281-1288
Published Date: 25 October 2022
PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far
Di Palma T, Zannini M
OncoTargets and Therapy 2022, 15:1273-1280
Published Date: 21 October 2022
Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study [Retraction]
Wang R, Wu Q
OncoTargets and Therapy 2022, 15:1271-1272
Published Date: 21 October 2022
Immunotherapy for Urothelial Carcinoma: Focus on Clinical Utility of Nivolumab
Chiang RS, Glover MJ, Khaki AR, Srinivas S
OncoTargets and Therapy 2022, 15:1259-1269
Published Date: 20 October 2022
Exosomal Tenascin-c Induces Proliferation and Invasion of Pancreatic Cancer Cells by WNT Signaling [Retraction]
Qian S, Tan X, Liu X, Liu P, Wu Y
OncoTargets and Therapy 2022, 15:1257-1258
Published Date: 20 October 2022
CCNB1 Expedites the Progression of Cervical Squamous Cell Carcinoma via the Regulation by FOXM1 [Retraction]
Li S, Liu N, Piao J, Meng F, Li Y
OncoTargets and Therapy 2022, 15:1255-1256
Published Date: 20 October 2022
ALK-Positive Anaplastic Large-Cell Lymphoma in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review
Yu Q, Zhao Z, Wang H, Wang L
OncoTargets and Therapy 2022, 15:1245-1253
Published Date: 19 October 2022
Spermidine Promotes Nb CAR-T Mediated Cytotoxicity to Lymphoma Cells Through Elevating Proliferation and Memory
Wang H, Jiang D, Liu L, Zhang Y, Qin M, Qu Y, Wang L, Wu S, Zhou H, Xu T, Xu G
OncoTargets and Therapy 2022, 15:1229-1243
Published Date: 18 October 2022
Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year After Standard Treatment
Yu C, Jiang L, Yang D, Dong X, Yu R, Yu H
OncoTargets and Therapy 2022, 15:1221-1228
Published Date: 17 October 2022
Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages
Reyes-Vallejo T, Conde-Rodríguez I, Serna-Villalobos J, Ramírez-Díaz I, Pérez-Villalobos G, Delgado-López G, Vazquez-Zamora VJ, Gutiérrez-Quiroz CT, Ávila-Jiménez L, García-Carrancá A, Martínez-Acosta L, Santos-López G, Reyes-Leyva J, Vallejo-Ruiz V
OncoTargets and Therapy 2022, 15:1211-1220
Published Date: 13 October 2022
Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations
Petrini I, Giaccone G
OncoTargets and Therapy 2022, 15:1197-1210
Published Date: 12 October 2022
Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments
Gordon A, Johnston E, Lau DK, Starling N
OncoTargets and Therapy 2022, 15:1183-1196
Published Date: 11 October 2022
Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy
Chou CL, Chen TJ, Li WS, Lee SW, Yang CC, Tian YF, Lin CY, He HL, Wu HC, Shiue YL, Li CF, Kuo YH
OncoTargets and Therapy 2022, 15:1171-1181
Published Date: 11 October 2022
The Predictive Value of Systemic Inflammatory Factors in Advanced, Metastatic Esophageal Squamous Cell Carcinoma Patients Treated with Camrelizumab
Liu J, Gao D, Li J, Hu G, Liu J, Liu D
OncoTargets and Therapy 2022, 15:1161-1170
Published Date: 10 October 2022
Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine
Fuller RN, Kabagwira J, Vallejos PA, Folkerts AD, Wall NR
OncoTargets and Therapy 2022, 15:1147-1160
Published Date: 10 October 2022
Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 [Corrigendum]
Wang J, Li H, Xia C, Yang X, Dai B, Tao K, Dou K
OncoTargets and Therapy 2022, 15:1143-1145
Published Date: 10 October 2022
Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways
Janowski M, Ulańczyk Z, Łuczkowska K, Sobuś A, Rogińska D, Pius-Sadowska E, Gniot M, Kozłowski K, Lewandowski K, Helbig G, Machaliński B, Paczkowska E
OncoTargets and Therapy 2022, 15:1123-1141
Published Date: 10 October 2022
Long Non-Coding RNA EGOT Promotes the Malignant Phenotypes of Hepatocellular Carcinoma Cells and Increases the Expression of HMGA2 via Down-Regulating miR-33a-5p [Retraction]
Wu S, Ai H, Zhang K, Yun H, Xie F
OncoTargets and Therapy 2022, 15:1121-1122
Published Date: 5 October 2022
Synergistic Suppression Effect on Tumor Growth of Acute Myeloid Leukemia by Combining Cytarabine with an Engineered Oncolytic Vaccinia Virus [Retraction]
Peng J, Wang S, Fan W, Li S, Wu Y, Mou X, Wang J, Tong X
OncoTargets and Therapy 2022, 15:1119-1120
Published Date: 13 October 2022
Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors
Miller RE, Elyashiv O, El-Shakankery KH, Ledermann JA
OncoTargets and Therapy 2022, 15:1105-1117
Published Date: 4 October 2022
A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects
Polychronidis G, Murtha-Lemekhova A, Fuchs J, Karathanasi E, Hoffmann K
OncoTargets and Therapy 2022, 15:1095-1103
Published Date: 3 October 2022
Efficacy and Safety of Regorafenib with or without PD-1 Inhibitors as Second-Line Therapy for Advanced Hepatocellular Carcinoma in Real-World Clinical Practice
Liu K, Wu J, Xu Y, Li D, Huang S, Mao Y
OncoTargets and Therapy 2022, 15:1079-1094
Published Date: 1 October 2022
Efficacy and Safety of Pyrotinib in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Multicenter, Retrospective, Real-World Study
Zhang X, Li Z, Han L, Lv Z, Teng Y, Cui X, Zhou C, Wu H, Fang W, Xu L, Zhao S, Song C, Zheng Y, Gao T, Li M
OncoTargets and Therapy 2022, 15:1067-1078
Published Date: 28 September 2022
ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]
Huang W, Zhu J, Shi H, Wu Q, Zhang C
OncoTargets and Therapy 2022, 15:1063-1065
Published Date: 27 September 2022
Cetuximab and Dabrafenib Plus Trametinib for Untreated Colonic Metastasis of BRAFV600E Mutant Primary Lung Adenocarcinoma with Signet Ring Cell Features: An Interesting and Rare Case Report
Jiang S, Wu Y, Wei W, Wang Z, Wang Q
OncoTargets and Therapy 2022, 15:1057-1062
Published Date: 26 September 2022
Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma
Sayegh N, Tripathi N, Agarwal N, Swami U
OncoTargets and Therapy 2022, 15:1047-1055
Published Date: 25 September 2022
Effects of Combined Inhibition of STAT3 and VEGFR2 Pathways on the Radiosensitivity of Non-Small-Cell Lung Cancer Cells [Retraction]
Hu C, Zhuang W, Qiao Y, Liu B, Liu L, Hui K, Jiang X
OncoTargets and Therapy 2022, 15:1045-1046
Published Date: 23 September 2022
Correlations of Microvascular Blood Flow of Contrast-Enhanced Ultrasound and HGF/c-Met Signaling Pathway with Clinicopathological Features and Prognosis of Patients with Hepatocellular Carcinoma [Retraction]
Zhuang PH, Xu L, Gao L, Lu W, Ruan LT, Yang J
OncoTargets and Therapy 2022, 15:1043-1044
Published Date: 23 September 2022
HS3ST2 and Its Related Molecules as Potential Biomarkers for Predicting Lymph Node Metastasis in Patients with Colorectal Cancer [Retraction]
Gao G, Shi X, Shen J
OncoTargets and Therapy 2022, 15:1041-1042
Published Date: 23 September 2022
Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells [Retraction]
Zhang B, Wu J, Guo P, Wang Y, Fang Z, Tian J, Yu Y, Teng W, Luo Y, Li Y
OncoTargets and Therapy 2022, 15:1039-1040
Published Date: 23 September 2022
A Unique Three-Way Variant Philadelphia Chromosome t(6;9;22)(p21.3;q34;q11.2) in a Newly Diagnosed Patient with Chronic Myeloid Leukemia Responded to Flumatinib
Chen L, Zhang J, Yang N, Tan N, Meng D, Zhang F, Qi Y, Wu G, Li Z
OncoTargets and Therapy 2022, 15:1033-1037
Published Date: 20 September 2022
Molecular Characteristics and the Effect of KRAS Mutation on the Prognosis of Immunotherapy in Non-Small Cell Lung Cancer in Xinjiang, China
Gu G, Yu B, Wan H, Lu S, Zhu X, Zhao Y, Fuxi Y, Liu C
OncoTargets and Therapy 2022, 15:1021-1032
Published Date: 21 September 2022
PTEN Expression Was Significantly Associated with PD-L1 Score but Not with EBV Infection in Gastric Cancer
Cao D, Su T, Wu Y, Jia Z, Fu Y, Sun Y, Jin M, Wang Y, Yi J, Cui Y, Zhang Y, Lv H, Qu L, Jiang J, Cao X
OncoTargets and Therapy 2022, 15:1011-1020
Published Date: 21 September 2022
Circular RNA Controls Tumor Occurrence and Development via Cell Cycle Regulation
Liu F, Qu R, Yang L, Shi G, Hao S, Hu C
OncoTargets and Therapy 2022, 15:993-1009
Published Date: 15 September 2022
Long Noncoding RNA LINC00525 Promotes the Aggressive Phenotype of Chordoma Through Acting as a microRNA-505-3p Sponge and Consequently Raising HMGB1 Expression [Retraction]
Li L, Lv G, Wang B, Ma H
OncoTargets and Therapy 2022, 15:991-992
Published Date: 16 September 2022
Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma
Takaoka H, Terai H, Emoto K, Shigematsu L, Ito F, Saito A, Okada M, Ohgino K, Ikemura S, Yasuda H, Nakachi I, Kawada I, Fukunaga K, Soejima K
OncoTargets and Therapy 2022, 15:981-989
Published Date: 14 September 2022
Case Report and Review of Literature: Camrelizumab Combined with Fuzuloparib and Apatinib for Platinum-Resistant Recurrent Ovarian Cancer
Wu Y, Zhang X, Li L, Yang W, Yan Z, Gu C, Zhang Z, Zhou J, Liu L, Ye M, Meng Y
OncoTargets and Therapy 2022, 15:973-979
Published Date: 12 September 2022
Role of the JNK Pathway in Bladder Cancer
Lee EH, Kim HT, Chun SY, Chung JW, Choi SH, Lee JN, Kim BS, Yoo ES, Kwon TG, Kim TH, Ha YS
OncoTargets and Therapy 2022, 15:963-971
Published Date: 5 September 2022
Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple Myeloma
Kareem SS, Viswanathan N, Sahebjam S, Tran ND, Gatewood T, Tobon K, Baz R, Piña Y, Shain KH, Mokhtari S
OncoTargets and Therapy 2022, 15:953-962
Published Date: 6 September 2022
Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient’s CDK12 Mutation: A Case Report
Zhu S, Bao Y, Zheng L, Zhao J, Chen Y, Huang R, Sun G, Zhao F, Zhang X, Liang J, Chen J, Wang Z, Ni Y, Chen N, Shen P, Zeng H
OncoTargets and Therapy 2022, 15:947-952
Published Date: 2 September 2022
Capmatinib in MET Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma with Extensive Central Nervous System Metastasis
Kim TW, Lee KM, Lee SH
OncoTargets and Therapy 2022, 15:941-946
Published Date: 31 August 2022
Establishment of Nomogram Model for Minimally Invasive Treatment of Small Hepatocellular Carcinoma Based on CD8+T Cell Counts
Pu Q, Yu L, Wang X, Yan H, Xie Y, Du J, Yang Z
OncoTargets and Therapy 2022, 15:925-940
Published Date: 31 August 2022
Tumor Heterogeneity and Drug Resistance Mutations Using ctDNA in Metastatic EGFR Mutation-Positive Lung Adenocarcinoma: A Case Report
Sun J, Sun G, Lu K, Xu L, Qu X, Cheng Y, Pan E, Yang P, Wu T, Zhang Y, He H
OncoTargets and Therapy 2022, 15:919-923
Published Date: 30 August 2022
Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenoma in the Clivus Region: A Case Report
Zhang Y, Wu D, Wang R, Luo M, Wang D, Wang K, Ai Y, Zheng L, Zhang Q, Shi L
OncoTargets and Therapy 2022, 15:913-918
Published Date: 29 August 2022
Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer
Jang A, Rauterkus GP, Vaishampayan UN, Barata PC
OncoTargets and Therapy 2022, 15:897-912
Published Date: 26 August 2022
Remission from the 5-Fu-Based Chemotherapy to Gemcitabine-Based Chemotherapy-Based on the Pathological Classification of Periampullary Carcinoma: A Case Report and Literature Review
Hu W, Duan Z, Zhang Y, Liu J, Bao J, Gao R, Tang Y, Liu T, Xiong H, Li W, Fu X, Liao S, Fang L, Liang B
OncoTargets and Therapy 2022, 15:891-896
Published Date: 25 August 2022
Long-Term Survival of FOLFIRINOX +toripalimab in a Patient with Metastatic Pancreatic Ductal Adenocarcinoma: A Case Report
Jiang T, Gao C, Luo Y, Ye Z, Wang B
OncoTargets and Therapy 2022, 15:883-890
Published Date: 25 August 2022
Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies
Miura S, Jung HA, Lee SY, Lee SH, Lee MK, Lee YC, Hochmair MJ, Yang CT, Märten A, Yang JCH, Popat S
OncoTargets and Therapy 2022, 15:873-882
Published Date: 22 August 2022
IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Retraction]
Li Y, Chen G, Han Z, Cheng H, Qiao L, Li Y
OncoTargets and Therapy 2022, 15:871-872
Published Date: 22 August 2022
Clinical Significance of SLP-2 in Hepatocellular Carcinoma Tissues and Its Regulation in Cancer Cell Proliferation, Migration, and EMT [Retraction]
Huang Y, Chen Y, Lin X, Lin Q, Han M, Guo G
OncoTargets and Therapy 2022, 15:869-870
Published Date: 18 August 2022
RPL38 Regulates the Proliferation and Apoptosis of Gastric Cancer via miR-374b-5p/VEGF Signal Pathway [Retraction]
Ji H, Zhang X
OncoTargets and Therapy 2022, 15:867-868
Published Date: 18 August 2022
Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives
Awada A, Ahmad S, McKenzie ND, Holloway RW
OncoTargets and Therapy 2022, 15:853-866
Published Date: 10 August 2022
Emodin Suppresses Proliferation, Migration and Invasion in Ovarian Cancer Cells by down Regulating ILK in vitro and in vivo [Retraction]
Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS
OncoTargets and Therapy 2022, 15:851-852
Published Date: 10 August 2022
MicroRNA-212 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induces Apoptosis by Targeting FOXA1 [Retraction]
Tu H, Wei G, Cai Q, Chen X, Sun Z, Cheng C, Zhang L, Feng Y, Zhou H, Zhou B, Zeng T
OncoTargets and Therapy 2022, 15:849-850
Published Date: 10 August 2022
Long Non-Coding RNA LINC00239 Functions as a Competitive Endogenous RNA by Sponging microRNA-484 and Enhancing KLF12 Expression to Promote the Oncogenicity of Colorectal Cancer [Retraction]
Luo X, Yue M, Li C, Sun D, Wang L
OncoTargets and Therapy 2022, 15:847-848
Published Date: 5 August 2022
Antimetastatic Effect of Epigenetic Drugs, Hydralazine and Valproic Acid, in Ras-Transformed NIH 3T3 Cells [Corrigendum]
Pérez-Cárdenas E, Taja-Chayeb L, Trejo-Becerril C, Chanona-Vilchis J, Chávez-Blanco A, Domínguez-Gómez G, Langley E, García-Carrancá A, Dueñas-González A
OncoTargets and Therapy 2022, 15:845-846
Published Date: 4 August 2022
LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer [Expression of Concern]
Jia Z, Li W, Bian P, Liu H, Pan D, Dou Z
OncoTargets and Therapy 2022, 15:843-844
Published Date: 4 August 2022
MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Expression of Concern]
Yin Z, Ren W
OncoTargets and Therapy 2022, 15:841-842
Published Date: 4 August 2022
MicroRNA-139-3p Inhibits the Growth and Metastasis of Ovarian Cancer by Inhibiting ELAVL1 [Retraction]
Xue F, Li QR, Xu YH, Zhou HB
OncoTargets and Therapy 2022, 15:839-840
Published Date: 2 August 2022
Hepatoid Adenocarcinoma of the Lung: Beyond a Shadow of Doubt and Risk of High Mortality [Letter]
Zehra SS, Jahangir Z, Batool A
OncoTargets and Therapy 2022, 15:837-838
Published Date: 2 August 2022
Identification of a Rare BAIAP2-ROS1 Fusion and Clinical Benefit of Crizotinib in the Treatment of Advanced Lung Adenocarcinoma: A Case Report
Lin Y, Lei Y, Li L, Su X, Tian Q, Wu W
OncoTargets and Therapy 2022, 15:831-836
Published Date: 28 July 2022
Forkhead Box Protein A1 is a Prognostic Predictor and Promotes Tumor Growth of Gastric Cancer [Retraction]
Ren H, Zhang P, Tang Y, Wu M, Zhang W
OncoTargets and Therapy 2022, 15:829-830
Published Date: 29 July 2022
Role of Nrf2 Signaling Pathway in the Radiation Tolerance of Patients with Head and Neck Squamous Cell Carcinoma: An in vivo and in vitro Study [Retraction]
Wang T, Hu P, Li B, Zhang J, Cheng Y, Liang Y
OncoTargets and Therapy 2022, 15:827-828
Published Date: 28 July 2022
Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
Edaily S, Abdel-Razeq H
OncoTargets and Therapy 2022, 15:815-826
Published Date: 27 July 2022
Evaluating the Therapeutic Potential of Idecabtagene Vicleucel in the Treatment of Multiple Myeloma: Evidence to Date
Mann H, Comenzo RL
OncoTargets and Therapy 2022, 15:799-813
Published Date: 22 July 2022
Potassium Channels as a Target for Cancer Therapy: Current Perspectives
Zúñiga L, Cayo A, González W, Vilos C, Zúñiga R
OncoTargets and Therapy 2022, 15:783-797
Published Date: 20 July 2022
The Multifunction of miR-218-5p-Cx43 Axis in Breast Cancer [Expression of Concern]
Xia C, Jiang H, Ye F, Zhuang Z
OncoTargets and Therapy 2022, 15:781-782
Published Date: 18 July 2022
miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1 [Expression of Concern]
Wang M, Wu Q, Fang M, Huang W, Zhu H
OncoTargets and Therapy 2022, 15:779-780
Published Date: 18 July 2022
Meg3 Induces EMT and Invasion of Glioma Cells via Autophagy [Retraction]
Yang Z, Bian E, Xu Y, Ji X, Tang F, Ma C, Wang H, Zhao B
OncoTargets and Therapy 2022, 15:777-778
Published Date: 14 July 2022
Case Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation
Liu R, Wei W, Hou H, Cong P, Zhou Y, Yu X
OncoTargets and Therapy 2022, 15:771-776
Published Date: 11 July 2022
Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer
Wang K, Yang Y, Zheng S, Hu W
OncoTargets and Therapy 2022, 15:761-769
Published Date: 9 July 2022
Circular RNA circGSE1 Promotes Cervical Cancer Progression Through miR-138-5p/Vimentin [Retraction]
Fan S, Zhao S, Gao X, Qin Q, Guo Y, Yuan Z, Zhang M, Liu Q, Li H
OncoTargets and Therapy 2022, 15:759-760
Published Date: 12 July 2022
MicroRNA-769-5p Promotes the Growth of Glioma Cells by Targeting Lysine Methyltransferase 2A [Retraction]
Chang M, Yan P, Zhang B, Zhang G, Wang J, Ge H, Han N, Du C, Shi W, Tian Y
OncoTargets and Therapy 2022, 15:757-758
Published Date: 8 July 2022
Targeting KRASG12C-Mutated Advanced Colorectal Cancer: Research and Clinical Developments
Ji J, Wang C, Fakih M
OncoTargets and Therapy 2022, 15:747-756
Published Date: 7 July 2022
A Case of Pneumonia Masking Pleural Malignancy
Xu Q, Tian J, Huang L, Zhong Q, Xu Y, Liu L, Shi J
OncoTargets and Therapy 2022, 15:741-746
Published Date: 2 July 2022
Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma
Kuo YH, Lai HY, Chan TC, Hsing CH, Huang SK, Hsieh KL, Chen TJ, Li WS, Lu JC, Li CF
OncoTargets and Therapy 2022, 15:727-740
Published Date: 30 June 2022
Genetic Analysis and Combined Therapy of Surgery and Chemotherapy for the Progression-Free Survival of a Patient with Ovarian Carcinosarcoma: A Case Report and Literature Review
Guo S, Zhang X, Tang Q, Zhou M, Jiang D, Yu E
OncoTargets and Therapy 2022, 15:717-725
Published Date: 29 June 2022
Response of Scalp and Skull Metastasis to Anti-PD-1 Antibody Combined with Regorafenib Treatment in a Sorafenib-Resistant Hepatocellular Carcinoma Patient and a Literature Review
Long X, Zhang L, Wang WQ, Zhang EL, Lv X, Huang ZY
OncoTargets and Therapy 2022, 15:703-716
Published Date: 29 June 2022
LINC01436 Promotes the Progression of Gastric Cancer via Regulating miR-513a-5p/APE1 Axis [Retraction]
Lu M, Liu D, Li Y
OncoTargets and Therapy 2022, 15:701-702
Published Date: 23 June 2022
The Coexpression and Clinical Significance of Costimulatory Molecules B7-H1, B7-H3, and B7-H4 in Human Pancreatic Cancer [Retraction]
Chen Y, Sun J, Zhao H, Zhu D, Zhi Q, Song S, Zhang L, He S, Kuang Y, Zhang Z, Li D
OncoTargets and Therapy 2022, 15:699-700
Published Date: 23 June 2022
Development and Characterization of 3D Hybrid Spheroids for the Investigation of the Crosstalk Between B-Cell Non-Hodgkin Lymphomas and Mesenchymal Stromal Cells
Duś-Szachniewicz K, Gdesz-Birula K, Rymkiewicz G
OncoTargets and Therapy 2022, 15:683-697
Published Date: 17 June 2022
LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction]
Bi H, Shang Z, Jia C, Wu J, Cui B, Wang Q, Ou T
OncoTargets and Therapy 2022, 15:681-682
Published Date: 15 June 2022
Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and Combined Therapy for Advanced Sarcoma
Yao W, Du X, Wang J, Wang X, Zhang P, Niu X
OncoTargets and Therapy 2022, 15:669-679
Published Date: 14 June 2022
Leptomeningeal Metastatic L858R EGFR-mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent Pulsed Erlotinib
Kanbour A, Salih F, Abualainin W, Abdelrazek M, Szabados L, Al-Bozom I, Omar NE
OncoTargets and Therapy 2022, 15:659-667
Published Date: 14 June 2022
FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
Hong C, Wei J, Zhou T, Wang X, Cai J
OncoTargets and Therapy 2022, 15:651-657
Published Date: 10 June 2022
An Effective Hormonal Therapy for a Patient with Estrogen Receptor 1 (ESR1)-Amplified Metastatic Ovarian Cancer: A Case Report
Wang Y, Tan S, Pan E, Ma Y, Wu X, Yu Z, Jiang K
OncoTargets and Therapy 2022, 15:643-649
Published Date: 9 June 2022
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report
Hayashi A, Nakamichi S, Nakayama Y, Nagano A, Mikami E, Takano N, Tozuka T, Matsumoto M, Miyanaga A, Noro R, Terasaki Y, Kubota K, Seike M, Gemma A
OncoTargets and Therapy 2022, 15:637-642
Published Date: 7 June 2022
Successful Treatment of Metastatic Gallbladder Carcinoma with PD-L1 Expression by the Combination of PD-1 Inhibitor Plus Bevacizumab with Chemotherapy: A Case Report
Guo L, Zhang J, Liu X, Liu H, Zhang Y, Liu J
OncoTargets and Therapy 2022, 15:629-636
Published Date: 7 June 2022
Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review
Chen Z, Ding C, Zhang T, He Y, Jiang G
OncoTargets and Therapy 2022, 15:609-627
Published Date: 1 June 2022
EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma
Chen Q, Li Y, Cheng Q, Van Valkenburgh J, Sun X, Zheng C, Zhang R, Yuan R
OncoTargets and Therapy 2022, 15:597-608
Published Date: 30 May 2022
Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
Jiang H, Zhang H
OncoTargets and Therapy 2022, 15:587-596
Published Date: 27 May 2022
Upregulated RACK1 Attenuates Gastric Cancer Cell Growth and Epithelial–Mesenchymal Transition via Suppressing Wnt/β-Catenin Signaling [Retraction]
Zhu L, Chen W, Li G, Chen H, Liao W, Zhang L, Xiao X
OncoTargets and Therapy 2022, 15:585-586
Published Date: 20 May 2022
Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA
Li J, Chen S, Xue H, Wang H, Huang T, Xie H, He J, Ke C, Yu Z, Ni B
OncoTargets and Therapy 2022, 15:571-584
Published Date: 19 May 2022
SPINDOC is Highly Expressed in Pan-Cancer Samples and Can Promote the Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating Wnt/β-Catenin Signaling Pathway
Tong W, Yang L, Liu L, Liu X, Luo N
OncoTargets and Therapy 2022, 15:555-570
Published Date: 18 May 2022
Circular RNA circLRCH3 Inhibits Proliferation, Migration, and Invasion of Colorectal Cancer Cells Through miRNA-223/LPP Axis
Yang Y, Wang D, Tao K, Wang G
OncoTargets and Therapy 2022, 15:541-554
Published Date: 18 May 2022
Silencing circZFR Inhibits the Proliferation, Migration and Invasion of Human Renal Carcinoma Cells by Regulating miR-206 [Retraction]
Wang M, Gao Y, Liu J
OncoTargets and Therapy 2022, 15:539-540
Published Date: 18 May 2022
Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck
Schnoell J, Jank BJ, Kadletz-Wanke L, Stoiber S, Gurnhofer E, Schlederer M, Heiduschka G, Kenner L
OncoTargets and Therapy 2022, 15:531-538
Published Date: 16 May 2022
RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum]
Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y
OncoTargets and Therapy 2022, 15:529-530
Published Date: 13 May 2022
Gastric H+/K+-ATPase Expression in Normal Laryngeal Tissue and Laryngeal Carcinoma [Corrigendum]
Bao YY, Jiang Q, Li ZW, Yu E, Zhou SH, Yao HT, Fan J, Yong WW
OncoTargets and Therapy 2022, 15:527-528
Published Date: 12 May 2022
Inhibition of Migration, Invasion and Drug Resistance of Pancreatic Adenocarcinoma Cells – Role of Snail, Slug and Twist and Small Molecule Inhibitors [Corrigendum]
Kaşıkcı E, Aydemir E, Bayrak ÖF, Şahin F
OncoTargets and Therapy 2022, 15:523-526
Published Date: 11 May 2022
A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model [Corrigendum]
Li XL, Zeng S, He HP, Zeng X, Peng LL, Chen LG
OncoTargets and Therapy 2022, 15:521-522
Published Date: 6 May 2022
TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer
Liu X, Zhou T, Wang Y, Pei M, Wang G, Chu W, Wang Q, Du S, Wang H, Wang C
OncoTargets and Therapy 2022, 15:509-520
Published Date: 3 May 2022
The Development of Non-Invasive Diagnostic Tools in Bladder Cancer
Schulz A, Loloi J, Pina Martina L, Sankin A
OncoTargets and Therapy 2022, 15:497-507
Published Date: 2 May 2022
Identification of 1,2,4-Oxadiazoles-Based Novel EGFR Inhibitors: Molecular Dynamics Simulation-Guided Identification and in vitro ADME Studies
Unadkat V, Rohit S, Parikh P, Patel K, Sanna V, Singh S
OncoTargets and Therapy 2022, 15:479-495
Published Date: 2 May 2022
Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer
Schlam I, Nunes R, Lynce F
OncoTargets and Therapy 2022, 15:471-478
Published Date: 28 April 2022
MicroRNA-423 Drug Resistance and Proliferation of Breast Cancer Cells by Targeting ZFP36 [Retraction]
Xia W, Liu Y, Du Y, Cheng T, Hu X, Li X
OncoTargets and Therapy 2022, 15:469-470
Published Date: 2 May 2022
Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations
Niedbała M, Malarz K, Sharma G, Kramer-Marek G, Kaspera W
OncoTargets and Therapy 2022, 15:437-468
Published Date: 28 April 2022
Targeting TP53-Mutated Acute Myeloid Leukemia: Research and Clinical Developments
Granowicz EM, Jonas BA
OncoTargets and Therapy 2022, 15:423-436
Published Date: 21 April 2022
Migfilin: Cell Adhesion Effect and Comorbidities
Duan B, Qin Z, Gu X, Li Y
OncoTargets and Therapy 2022, 15:411-422
Published Date: 19 April 2022
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer
Di Marino P, Chiapperino C, Primavera FC, Martino MT, Brocco D, Carella C, Grassadonia A, Tinari N, De Tursi M
OncoTargets and Therapy 2022, 15:407-410
Published Date: 11 April 2022
Hereditary Gynecologic Cancer Syndromes – A Narrative Review
Kostov S, Watrowski R, Kornovski Y, Dzhenkov D, Slavchev S, Ivanova Y, Yordanov A
OncoTargets and Therapy 2022, 15:381-405
Published Date: 8 April 2022
Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib
Owen S, Alken S, Alshami J, Guiot MC, Kavan P, Reardon DA, Muanza T, Gibson N, Pemberton K, Solca F, Cseh A, Saran F
OncoTargets and Therapy 2022, 15:367-380
Published Date: 8 April 2022
CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Progressive Muscular Dystrophy: A Case Report
Chen L, Xu B, Liu W, Wang D, Xu J, Mao X, Xiao M, Zhou J, Xiao Y
OncoTargets and Therapy 2022, 15:361-366
Published Date: 8 April 2022
Clinical Response to Neoadjuvant Immunotherapy Combined with Targeted Therapy and Chemotherapy in Oral Squamous Cell Carcinoma: Experience in Three Patients
Tian Y, Zhang L, Jin N, Wan Z, Zhang H, Zhang H, Zhang L
OncoTargets and Therapy 2022, 15:353-359
Published Date: 8 April 2022
Treatment of PD-1 Inhibitor-Associated Toxic Epidermal Necrolysis: A Case Report and Brief Review
Zhao Y, Cao Y, Wang X, Qian T
OncoTargets and Therapy 2022, 15:345-351
Published Date: 8 April 2022
An Innovative Site-Specific Anti-HER2 Antibody-Drug Conjugate with High Homogeneity and Improved Therapeutic Index
Hui X, Yuan C, Cao W, Ge W, Zhang D, Dan M, Zhao Q, Liu B, Yao B
OncoTargets and Therapy 2022, 15:331-343
Published Date: 8 April 2022
The Silencing of LncRNA-H19 Decreases Chemoresistance of Human Glioma Cells to Temozolomide by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway [Retraction]
Jia L, Tian Y, Chen Y, Zhang G
OncoTargets and Therapy 2022, 15:329-330
Published Date: 7 April 2022
Remarkable Response to the Triplet Combination of Olaparib with Pembrolizumab and Bevacizumab in the Third-Line Treatment of an Ovarian Clear Cell Carcinoma Patient with an ARID1A Mutation: A Case Report
Zhao Y, Jiang Y
OncoTargets and Therapy 2022, 15:323-328
Published Date: 2 April 2022
Genetic Testing and Immunotherapy for Intracranial Inflammatory Myofibroblastic Tumor: A Case Report
Meng X, Zhang L, Wang Q, Chen J, Zhang C, Tao R, Wang Y
OncoTargets and Therapy 2022, 15:313-321
Published Date: 1 April 2022
CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming
Li M, Che N, Jin Y, Li J, Yang W
OncoTargets and Therapy 2022, 15:299-311
Published Date: 26 March 2022
The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
Jiang H, Zheng H, Xia C, Li X, Wang G, Zhao T, Cui X, Wang R, Liu Y
OncoTargets and Therapy 2022, 15:291-298
Published Date: 22 March 2022
Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives
Katt WP, Aplin C, Cerione RA
OncoTargets and Therapy 2022, 15:277-290
Published Date: 19 March 2022
Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH- Gastric Cancer
Dai L, Jin X, Wang L, Wang H, Yan Z, Wang G, Liang B, Huang F, Luo Y, Chen T, Wang Q
OncoTargets and Therapy 2022, 15:267-275
Published Date: 16 March 2022
Progression-Free Survival of a Patient with Advanced Hepatocellular Carcinoma Treated with Adoptive Cell Therapy Using Natural Killer Cells: A Case Report
Hong G, Xie S, Guo Z, Zhang D, Ge S, Zhang S, Gao W
OncoTargets and Therapy 2022, 15:255-266
Published Date: 15 March 2022
A Novel LOC101927967 Intergenic Region ALK Fusion Identified by NGS and Validated by IHC and FISH in a Patient with Early Stage Adenocarcinoma of Lung
Jia X, He Q, Xing X, Yang Y, Ma Y
OncoTargets and Therapy 2022, 15:251-254
Published Date: 14 March 2022
Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients
Delforge M, Raddoux J, Antonis C, Clement C, Kint N, Vanhellemont A, Bravetti J, Vandenberghe P
OncoTargets and Therapy 2022, 15:243-250
Published Date: 14 March 2022
Undifferentiated Large Cell Carcinoma of the Thymus Associated with Plasma-Cell Type Castleman Disease-Like Reaction: A Case Series
Han L, Wang EH, Wang L
OncoTargets and Therapy 2022, 15:237-242
Published Date: 10 March 2022
Epigenetic Activation of lncRNA MIR155HG Mediated by Promoter Hypomethylation and SP1 is Correlated with Immune Infiltration in Glioma
Wu X, Wan Q, Wang J, Hou P, Zhang Q, Wang Q, Lu X
OncoTargets and Therapy 2022, 15:219-235
Published Date: 9 March 2022
HMGB1/RAGE Axis Mediates the Apoptosis, Invasion, Autophay, and Angiogenesis of the Renal Cell Carcinoma [Corrigendum]
Wu CZ, Zheng JJ, Bai YH, Xia P, Zhang HC, Guo Y
OncoTargets and Therapy 2022, 15:217-218
Published Date: 9 March 2022
miR-132 Can Inhibit Glioma Cells Invasion and Migration by Target MMP16 in vitro [Retraction]
Wang H, Li X, Wu C, Wu Z, Li Y, Yang T, Chen G, Xie X, Huang Y, Du Z, Zhou YX
OncoTargets and Therapy 2022, 15:215-216
Published Date: 4 March 2022
Airway Fusobacterium is Associated with Poor Response to Immunotherapy in Lung Cancer
Chu S, Cheng Z, Yin Z, Xu J, Wu F, Jin Y, Yang G
OncoTargets and Therapy 2022, 15:201-213
Published Date: 28 February 2022
Targeted Therapy for Relapsed/Refractory Follicular Lymphoma: Focus on Clinical Utility of Tazemetostat
Raychaudhuri R, Ujjani C
OncoTargets and Therapy 2022, 15:193-199
Published Date: 27 February 2022
Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma
Xu Y, Zhou X, Zhang S, Nanding A, Xuan Q
OncoTargets and Therapy 2022, 15:181-191
Published Date: 25 February 2022
PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components
O'Sullivan Coyne G, Karlovich C, Wilsker D, Voth AR, Parchment RE, Chen AP, Doroshow JH
OncoTargets and Therapy 2022, 15:165-180
Published Date: 24 February 2022
Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine
Zhang LS, Wang J, Xu MZ, Wu TM, Huang SM, Cao HY, Sun AN, Liu SB, Xue SL
OncoTargets and Therapy 2022, 15:159-164
Published Date: 18 February 2022
Genetic and Clinicopathologic Characteristics of Papillary Thyroid Carcinoma in the Chinese Population: High BRAF Mutation Allele Frequency, Multiple Driver Gene Mutations, and RET Fusion May Indicate More Advanced TN Stage
Wang Z, Tang P, Hua S, Gao J, Zhang B, Wan H, Wu Q, Zhang J, Chen G
OncoTargets and Therapy 2022, 15:147-157
Published Date: 9 February 2022
LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression [Retraction]
Duan Y, Zhao M, Jiang M, Li Z, Ni C
OncoTargets and Therapy 2022, 15:145-146
Published Date: 8 February 2022
Treatment Patterns and Outcomes Among Elderly Glioblastoma Patients in Riyadh, Saudi Arabia
Marie A, Maklad A, AlTwairgi A, Aly M, Elyamany A, AlShaqweer W, Senosy M, Balbaid A
OncoTargets and Therapy 2022, 15:135-144
Published Date: 2 February 2022
lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis [Retraction]
Wei P, Yang J, Zhang D, Cui M, Li L
OncoTargets and Therapy 2022, 15:133-134
Published Date: 28 January 2022
Aberrant miR-362-3p is Associated with EBV-Infection and Prognosis in Nasopharyngeal Carcinoma and Involved in Tumor Progression by Targeting JMJD2A
Wang X, Chen P
OncoTargets and Therapy 2022, 15:121-131
Published Date: 28 January 2022
Knockdown of Long Noncoding RNA 00152 (LINC00152) Inhibits Human Retinoblastoma Progression [Retraction]
Li S, Wen D, Che S, Cui Z, Sun Y, Ren H, Hao J
OncoTargets and Therapy 2022, 15:119-120
Published Date: 26 January 2022
Long Noncoding RNA UCA1 Accelerates Nasopharyngeal Carcinoma Cell Progression by Modulating miR-124-3p/ITGB1 Axis [Retraction]
Liu C, Zhang H, Liu H
OncoTargets and Therapy 2022, 15:117-118
Published Date: 25 January 2022
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia
De Santis S, Monaldi C, Mancini M, Bruno S, Cavo M, Soverini S
OncoTargets and Therapy 2022, 15:103-116
Published Date: 25 January 2022
Stichoposide C Exerts Anticancer Effects on Ovarian Cancer by Inducing Autophagy via Inhibiting AKT/mTOR Pathway
Liu F, Tang L, Tao M, Cui C, He D, Li L, Liao Y, Gao Y, He J, Sun F, Lin H, Li H
OncoTargets and Therapy 2022, 15:87-101
Published Date: 21 January 2022
Knockdown of Fibrous Sheath Interacting Protein 1 Expression Reduces Bladder Urothelial Carcinoma Cell Proliferation and Induces Apoptosis via Inhibition of the PI3K/AKT Pathway [Retraction]
Sun M, Chen Z, Tan S, Liu C, Zhao W
OncoTargets and Therapy 2022, 15:85-86
Published Date: 20 January 2022
LncRNA GA-Binding Protein Transcription Factor Subunit Beta-1 Antisense RNA 1 Inhibits Renal Carcinoma Growth Through an MiR-1246/Phosphoenolpyruvate Carboxykinase 1 Pathway [Retraction]
Gao S, Zhang F, Sun H, Yang X
OncoTargets and Therapy 2022, 15:83-84
Published Date: 20 January 2022
Bone Marrow Mesenchymal Stem Cells-Derived Exosomal miR-425-5p Inhibits Acute Myeloid Leukemia Cell Proliferation, Apoptosis, Invasion and Migration by Targeting WTAP [Retraction]
Zhang L, Khadka B, Wu J, Feng Y, Long B, Xiao R, Liu J
OncoTargets and Therapy 2022, 15:81-82
Published Date: 20 January 2022
Traditional Chinese Medicine Astragalus Polysaccharide Enhanced Antitumor Effects of the Angiogenesis Inhibitor Apatinib in Pancreatic Cancer Cells on Proliferation, Invasiveness, and Apoptosis [Corrigendum]
Wu J, Wang J, Su Q, Ding W, Li T, Yu J, Cao B
OncoTargets and Therapy 2022, 15:77-79
Published Date: 20 January 2022
Superselective Prostate Artery Embolization for Treatment of Severe Haematuria Secondary to Rapid Progression of Treatment-Induced Neuroendocrine Prostate Cancer: A Case Report
Deng L, Li C, He Q, Huang C, Chen Q, Zhang S, Wang L, Gan Y, Long Z
OncoTargets and Therapy 2022, 15:67-75
Published Date: 20 January 2022
Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations
Vaynrub A, Healey JH, Tap W, Vaynrub M
OncoTargets and Therapy 2022, 15:53-66
Published Date: 13 January 2022
Prognostic Implications of Six Altered Genes in Asian Non-Surgical Esophageal Carcinoma Patients Treated with Chemoradiotherapy
Feng A, Yang N, Yu R, Liu J, Pang J, Wu X, Shao Y, Yang Z, Dai H
OncoTargets and Therapy 2022, 15:41-51
Published Date: 13 January 2022
RETRACTED ARTICLE: Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study
Wang R, Wu Q
OncoTargets and Therapy 2022, 15:31-39
Published Date: 13 January 2022
Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer
Berke TP, Slight SH, Hyder SM
OncoTargets and Therapy 2022, 15:23-30
Published Date: 8 January 2022
Secondary Nasopharyngeal Mixed Adenoneuroendocrine Carcinoma After Radical Radiotherapy for Nasopharyngeal Carcinoma: A Rare Case and Literature Review [Corrigendum]
Huang D, Huang C, Wang H, He L, Zhang J, Zhong X, Guo Z, Yuan Y, Zhang W
OncoTargets and Therapy 2022, 15:21-22
Published Date: 7 January 2022
Multiple Primary Lung Tumors of Different Pathological Types Including Squamous Cell Carcinoma, Adenocarcinoma, and Mixed Squamous Cell and Glandular Papilloma: A Case Report
Wang X, Liu H, Zhai D, Qin Y, Fan C, Zhang D
OncoTargets and Therapy 2022, 15:13-19
Published Date: 6 January 2022
Successful Treatment of Primary CNS Extranodal NK/T-Cell Lymphoma with Surgery and Chemotherapy Combined with Sintilimab: A Case Report and Literature Review
Qin L, Li Y, He Y, Zeng R, Pan T, Zuo Y, Xiao L, Zhou H
OncoTargets and Therapy 2022, 15:1-11
Published Date: 6 January 2022